Dipl.-Stat. Nadine Bonberg








  • Bonberg,N., Taeger,D., Gawrych,K., Johnen,G., Banek,S., Schwentner,C., Sievert,K.-D., Wellhäußer,H., Kluckert,M., Leng,G., Nasterlack,M., Stenzl,A., Behrens,T., Brüning,T., Pesch,B. (2012), Chromosomal instability and bladder cancer – The UroVysion™ test in the UroScreen study, BJU Int. in press
  • Banek,S., Schwentner,C., Taeger,D., Pesch,B., Nasterlack,M., Leng,G., Gawrych,K., Bonberg,N., Johnen,G., Kluckert,M., Sievert,K.D., Brüning,T., Stenzl,A. (2012), Prospective evaluation of the UroVysion test to detect bladder cancer: results from the UroScreen-study, Urol Oncol 2012 [online ahead of print May 22, 2012]. http://dx.doi.org/10.1016/j.urolonc.2012 04.015.
  • Huber,S., Schwentner,C., Taeger,D., Pesch,B., Nasterlack,M., Leng,G., Mayer,T., Gawrych,K., Bonberg,N., Pelster,M., Johnen,G., Bontrup,H., Wellhäußer,H., Bierfreund,H.G., Wiens,C., Bayer,C., Eberle,F., Scheuermann,B., Kluckert,M., Feil,G., Brüning,T., Stenzl,A. (2012), Nuclear matrix protein-22: a prospective evaluation in a population at risk for bladder cancer. Results from the UroScreen study, BJU Int. doi: 10.1111/j.1464-410X.2011.10883.x.
  • Pesch,B., Nasterlack,M., Eberle,F., Bonberg,N., Taeger,D., Leng,G., Feil,G., Johnen,G., Ickstadt,K., Kluckert,M., Wellhäußer,H., Stenzl,A., Brüning,T. (2011), The role of haematuria in bladder cancer screening among men with former occupational exposure to aromatic amines, BJU Int 108, 546-552.
  • Pesch,B., Harth,V., Rabstein,S., Baisch,C., Schiffermann,M., Pallapies,D., Bonberg,N., Heinze,E., Spickenheuer,A., Justenhoven,C., Brauch,H., Hamann,U., Ko,Y., Straif,K. and Brüning,T. (2009), Night work and breast cancer - results from the German GENICA study, Scand J Work Environ Health 36, 134-141.